Impact on Patient Satisfaction About Realization of Ultrasound Dopplers at the Bed
February 12, 2019 updated by: Groupe Hospitalier Paris Saint Joseph
Organisation and logistic about realisation of vascular doppler ultrasound is something very eclectic . Need to shift patient from their bed , long waiting time and the effect on the hospital cost.
That's why vascular yard aim to practise these doppler ultrasound directly in the patients' room in the bed.
And like that evaluate the patient's satisfaction of this kind of coverage.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Observational
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients hospitalized in vascular yard of GHPSJ
Description
Inclusion Criteria:
- hospitalized in vascular yard
- indication of ultrasound doppler
- accept to participate
Exclusion Criteria:
- refuse to participate
- without ultrasound doppler indication.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
echo doppler at the bed
|
we practise the echo doppler at the patient 's bed
|
|
echo doppler in the vascular exploration platform
|
as usual , practising echo doppler in the medical platform
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
score of a satisfaction questionnaire
Time Frame: 24 hours
|
in the current practice every patient fill up a questionnaire named SAPHORA to evaluate their satisfaction
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: PRIOLLET Pascal, MD, GHPSJ
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 2, 2017
Primary Completion (Actual)
June 30, 2017
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
October 16, 2017
First Submitted That Met QC Criteria
October 23, 2017
First Posted (Actual)
October 25, 2017
Study Record Updates
Last Update Posted (Actual)
February 15, 2019
Last Update Submitted That Met QC Criteria
February 12, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- SAPHODOPPLER
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.